期刊文献+

人神经病靶标酯酶RNAi表达载体的构建及其对哺乳动物细胞中NTE表达的抑制 被引量:1

Construction of RNA interference expression vectors of human neuropathy target esterase and its inhibition for expression of NTE in mammalian cells
原文传递
导出
摘要 目的构建人神经病靶标酯酶(NTE)双链RNA的稳定表达载体。方法用Spe I和Xho I将pSUPER质粒中的H1 RNA聚合酶Ⅲ启动子及多克隆位点部分切下替换pcDNA3.1(+)载体中的巨嗜细胞病毒(CMV)启动子及其多克隆位点,构建了适合在哺乳动物细胞中表达具有干涉作用的小 RNA的载体pSUPER/neo,进而将针对NTE表达的双链DNA插入到BglⅡ和HindⅢ酶切的载体pSUPER /neo中构建NTE的双链RNA表达载体pSUPER/neo-NTE,后者被转染到COS7和SH-SY5Y细胞中, 采用蛋白质杂交和酶活力测定的方法,检测其表达效率并验证载体构建的正确性。结果构建了适合在真核细胞用抗生素筛选的NTE双链RNA表达载体pSUPER/neo-NTE。蛋白质杂交检测显示,转染细胞能有效抑制外源性NTE的表达;酶活力测定则显示其能有效地抑制内源性NTE的表达。结论采用启动子替换的策略,成功构建了NTE双链RNA的表达载体并在哺乳动物细胞内有效抑制NTE 的表达。 Objective To construct the RNA interference expression vector for explession of human neuropathy target esterase (NTE) gene in mammalian ceils. Methods Spe I and Xho I-digested insert from pSU-PER, which comprised HI RNA polymerase Ⅲ promoter and the multiple cloning sites, were cloned into the compatible in the pcDNA3.1 (+) to generate pSUPER/neo that could express small interfering RNA in mammalian ceils. The annealed oligos targeting the expression of NTE were ligated into pSUPER/neo vector digested with Bgl Ⅱ and Hind Ⅲ to generate pSUPER/neo-NTE, which was transfected into COS7 and SH-SY5Y ceils. The inhibitory effect of the expression of NTE was detected by western blot analysis and the enzyme activity assay. Results pSU- PER/neo-NTE could stably express double-stranded RNA of NTE. The expression of pSUPER/neo-NTE in COS7 and SH-SYSY ceils could efficiently inhibit the activity of NTE in the mammalian cells. Conclusion Stable eukaryotic expression vector of double-stranded RNA of NTE, pSUPER/neo-NTE, has been constructed successfully with promoter substitution strategy.
出处 《中华劳动卫生职业病杂志》 CAS CSCD 北大核心 2006年第1期27-30,共4页 Chinese Journal of Industrial Hygiene and Occupational Diseases
基金 国家自然科学基金(30140005 30470228)中科院择优支持回国工作基金(20010614083914)资助项目
关键词 遗传载体 RNA干涉 神经神经病靶标酯酶 真核细胞 Cenetie vectors RNA interference Neuropathy target esterase Eucaryotic cells
  • 相关文献

参考文献9

  • 1Johnson MK.Symposium introduction:retrospect and prospects for neuropathy target esterase(NTE) and the delayed polyneuropathy(OPIDP) induced by some organophosphorus esters.Chem Biol Interact,1993,87:339-346.
  • 2Barstead R.Genome-wide RNAi.Curr Opin Chem Biol,2001,5:63-66.
  • 3Bosher JM,Labouesse M.RNA interference:genetic wand and genetic watchdog.Nat Cell Biol,2000,2:E31-E36.
  • 4Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.Nature,2001,411:494-498.
  • 5Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells.Science,2002,296:550-553.
  • 6Sui G,Soohoo C,Affar el B,et al.A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.Proc Natl Acad Sci USA,2002,99:5515-5520.
  • 7Yi CE,Bekker JM,Miller G,et al.Specific and potent RNA interference in terminally differentiated myotubes.J Biol Chem,2003,278:934-939.
  • 8Johnson MK.Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential.Arch Toxicol,1977,37:113-115.
  • 9Gorun V,Proinov I,Baltesuc V,et al.Modified Ellman procedure for assay of cholinesterase in crude enzymatic preparations.Anal Biochem,1978,86:324-326.

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部